Understanding how cells work to produce better medications with fewer side effects has led to a Nobel Prize in Chemistry for a pair of American scientists.
Robert Lefkowitz and Brian Kobilka will share the $1.2-million prize for their research into G-protein-coupled receptors, the mechanisms that allow cells to respond to chemical messages, Reuters reported.
“Knowing what (the receptors) look like and how they function will provide us with the tools to make better drugs with fewer side effects,” Nobel committee chairman Sven Lidin said, Reuters reported.
The breakthrough will help doctors treat diseases such as diabetes, cancer and depression, for example.
“Around half of all medications act through these receptors, among them beta blockers, antihistamines and various kinds of psychiatric medications,” the Nobel Prize committee said, according to Reuters.
More from GlobalPost: John Gurdon, Shinya Yamanaka share Nobel Prize in medicine
Lefkowitz is a 69-year-old professor at Duke University and researcher at the Howard Hughes Medical Institute.
Kobilka, 57, worked with Lefkowitz at Duke before moving on to Stanford.
They did their research primarily in the 1980s, The Associated Press reported.
Their work allows a better understanding of how receptors in our bodies react and respond to stimuli such as an adrenaline rush, smells or taste.
The receptors act as gateways to the cells, and a better understanding how they work is vital for pharmaceutical companies.
Both men said they were sleeping when the call arrived.
“They passed the phone around and congratulated me,” Kobilka said, the AP reported.
“I guess they do that so you actually believe them. When one person calls you, it can be a joke, but when five people with convincing Swedish accents call you, then it isn't a joke.”
More from GlobalPost: David Wineland, Serge Haroche win 2012 Nobel prize in physics